Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Recent & Breaking News (TSX:VPH)

Valeo Pharma Enters into a Licensing Agreement for Canadian Rights to Heparin Biosimilar

Canada NewsWire July 8, 2019

Valeo Pharma reports its second quarter 2019 financial results

Canada NewsWire July 3, 2019

Valeo Pharma Announces Pricing of $0.50 Per Unit and Warrant Terms for its Prospectus Offering

Canada NewsWire May 27, 2019

Valeo Pharma Announces Short Form Prospectus Unit Offering and Refiling of Its Condensed Consolidated Interim Financial Statements and Related MD&A

GlobeNewswire May 1, 2019

Valeo Pharma to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire April 25, 2019

Valeo Pharma Inc. Reports 2019 First Quarter Results

Canada NewsWire March 27, 2019

Valeo Pharma Inc. Reports 2018 Fourth Quarter and Year End Results

Canada NewsWire February 28, 2019

CSE New Listing - Valeo Pharma Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile February 22, 2019

Valeo Pharma Announces Listing of its Shares on the Canadian Securities Exchange Under the Symbol VPH

Canada NewsWire February 20, 2019

Valeo Pharma Completes Private Placement

Canada NewsWire February 19, 2019